The Association between Serum Bilirubin Level and Electrochemical Skin Conductance in Chinese Patients with Type 2 Diabetes

Table 1

Baseline characteristics of 265 T2DM patients enrolled in the study.

	Mean ± SD
Age (years)	59.64 ± 12.83
Male/female	163/102
Duration of T2DM (years)	9.20 ± 7.84
SBP (mmHg)	129.53 ± 14.07
DBP (mmHg)	80.28 ± 9.20
HbA1c (%)	8.67 ± 2.18
BMI (kg/m^2)	24.53 ± 4.10
WHR	0.93 ± 0.07
ALT (U/L)	30.35 ± 20.77
AST (U/L)	22.97 ± 14.08
TG (mmol/L)	1.81 ± 1.93
CHO (mmol/L)	4.49 ± 1.23
LDL-C (mmol/L)	2.58 ± 0.88
HDL-C (mmol/L)	1.22 ± 2.91
Smokers (%)	76 (28.7%)
Alcohol consumption (%)	31 (11.7%)
Total bilirubin (μmol/L)	12.54 ± 4.48
Conjugated bilirubin (μmol/L)	3.34 ± 3.44
Unconjugated bilirubin (μmol/L)	9.27 ± 4.81
MNSI score	3.04 ± 2.31
NSS score	3.07 ± 2.78
NDS score	2.89 ± 2.59
DPN by SUDOSDCAN (%)	148 (53.0%)
Foot ESC (μS)	59.14 ± 21.95
Hand ESC (μS)	59.51 ± 21.95

Data are means (SD) and percentage (%). T2DM: type 2 diabetes mellitus; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; DPN: diabetic peripheral neuropathy; WHR: waist-hip ratio; HbA1c: glycated hemoglobin; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; CHO: cholesterol; TG: triglyceride; ALT: alanine aminotransferase; AST: aspartate aminotransferase; TBil: total bilirubin; CBil: conjugated bilirubin; UCBil: unconjugated bilirubin; NSS: neuropathy symptom score; NDS: neuropathy disability score; MNSI: Michigan Neuropathy Screening Instrument; ESC: electrochemical skin conductance.